SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS ARTICLE H impact

GeneSystem to Absorb Wholly Owned Subsidiary Kyungbo Electric

GeneSystem will absorb its wholly owned subsidiary Kyungbo Electric, with the merger scheduled to take effect on December 18, 2026. The electrical equipment manufacturer will cease to exist as a separate company; no new shares will be issued. The merger aims to consolidate business capabilities, reduce costs and improve resource management. Consolidated revenue and earnings will be unaffected because the subsidiary is already included in consolidated financial statements. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GeneSystem Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261015000167), on October 15, 2026, and is solely responsible for the information contained therein. (C)

363250.KQ

Story updates

05:53:23 AM UTC
SquawkNews
GeneSystem to Absorb Wholly Owned Subsidiary KyongBo Electric

GeneSystem will absorb its wholly owned subsidiary Kyungbo Electric, with the merger scheduled to take effect on December 18, 2026. The electrical equipment manufacturer will cease to exist as a separate company; no new shares will be issued. The merger aims to consolidate business capabilities, reduce costs and improve resource management. Consolidated revenue and earnings will be unaffected because the subsidiary is already included in consolidated financial statements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GeneSystem Co. Ltd.

published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261015000167), on October 15, 2026, and is solely responsible for the information contained therein. (C)